Skip to main content

Anidulafungin use while Breastfeeding

Medically reviewed by Drugs.com. Last updated on Jul 29, 2023.

Drugs containing Anidulafungin: Eraxis

Anidulafungin Levels and Effects while Breastfeeding

Summary of Use during Lactation

No information is available on the use of anidulafungin during breastfeeding. Because anidulafungin is >99% bound to plasma proteins and has poor oral bioavailability, it is unlikely to reach the milk and be absorbed by the infant. If anidulafungin is required by the mother, it is not a reason to discontinue breastfeeding.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Fluconazole, Miconazole

Substance Identification

Substance Name

Anidulafungin

CAS Registry Number

166663-25-8

Drug Class

Breast Feeding

Lactation

Milk, Human

Antifungal Agents

Echinocandins

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.